Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker

Background: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating monocyte populations in MM patients and their cor...

Full description

Bibliographic Details
Main Authors: Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady
Format: Article
Language:English
Published: AOSIS 2021-08-01
Series:African Journal of Laboratory Medicine
Subjects:
Online Access:https://ajlmonline.org/index.php/ajlm/article/view/1296
id doaj-813eadb309c54aef8d01b5cb7af0684e
record_format Article
spelling doaj-813eadb309c54aef8d01b5cb7af0684e2021-09-03T08:55:31ZengAOSISAfrican Journal of Laboratory Medicine2225-20022225-20102021-08-01101e1e810.4102/ajlm.v10i1.1296336Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic markerAsmaa M. Zahran0Hanaa Nafady-Hego1Sawsan M. Moeen2Hanan A. Eltyb3Mohammed M. Wahman4Asmaa Nafady5Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, AssiutDepartment of Microbiology and Immunology, Faculty of Medicine, Assiut University, AssiutDepartment of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, AssiutDepartment of Medical Oncology, South Egypt Cancer Institute, Assiut University AssiutDepartment of Clinical Oncology, South Valley University, QenaDepartment of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, QenaBackground: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating monocyte populations in MM patients and their correlation with disease severity. Methods: Peripheral monocytes from 20 patients with MM attending Assiut University Hospital in Assiut, Egypt, between October 2018 and August 2019 were processed using a flow cytometry procedure and stratified using the intensity of expression of CD14 and CD16 into classical (CD16−CD14++), intermediate (CD16+CD14++), and non-classical (CD16++CD14+) subsets. The data were compared with data from 20 healthy control participants with comparable age and sex. Results: In patients with MM, the percentage of classical monocytes was significantly lower (mean ± standard error: 77.24 ± 0.66 vs 83.75 ± 0.5), while those of non-classical (12.44 ± 0.5 vs 8.9 ± 0.34) and intermediate (10.3 ± 0.24 vs 7.4 ± 0.29) monocytes were significantly higher when compared with those of controls (all p 0.0001). Proportions of non-classical and intermediate monocytes correlated positively with serum levels of plasma cells, M-protein, calcium, creatinine and lactate dehydrogenase, and correlated negatively with the serum albumin level. Proportions of classical monocytes correlated positively with albumin level and negatively correlated with serum levels of M-protein, plasma cells, calcium, creatinine, and lactate dehydrogenase. Conclusion: Circulating monocyte subpopulations are skewed towards non-classical and intermediate monocytes in MM patients, and the intensity of this skewness increases with disease severity.https://ajlmonline.org/index.php/ajlm/article/view/1296multiple myelomaclassical monocytesintermediate monocytesnon-classical monocytesflow cytometry
collection DOAJ
language English
format Article
sources DOAJ
author Asmaa M. Zahran
Hanaa Nafady-Hego
Sawsan M. Moeen
Hanan A. Eltyb
Mohammed M. Wahman
Asmaa Nafady
spellingShingle Asmaa M. Zahran
Hanaa Nafady-Hego
Sawsan M. Moeen
Hanan A. Eltyb
Mohammed M. Wahman
Asmaa Nafady
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
African Journal of Laboratory Medicine
multiple myeloma
classical monocytes
intermediate monocytes
non-classical monocytes
flow cytometry
author_facet Asmaa M. Zahran
Hanaa Nafady-Hego
Sawsan M. Moeen
Hanan A. Eltyb
Mohammed M. Wahman
Asmaa Nafady
author_sort Asmaa M. Zahran
title Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
title_short Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
title_full Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
title_fullStr Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
title_full_unstemmed Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
title_sort higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in egypt: a possible prognostic marker
publisher AOSIS
series African Journal of Laboratory Medicine
issn 2225-2002
2225-2010
publishDate 2021-08-01
description Background: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating monocyte populations in MM patients and their correlation with disease severity. Methods: Peripheral monocytes from 20 patients with MM attending Assiut University Hospital in Assiut, Egypt, between October 2018 and August 2019 were processed using a flow cytometry procedure and stratified using the intensity of expression of CD14 and CD16 into classical (CD16−CD14++), intermediate (CD16+CD14++), and non-classical (CD16++CD14+) subsets. The data were compared with data from 20 healthy control participants with comparable age and sex. Results: In patients with MM, the percentage of classical monocytes was significantly lower (mean ± standard error: 77.24 ± 0.66 vs 83.75 ± 0.5), while those of non-classical (12.44 ± 0.5 vs 8.9 ± 0.34) and intermediate (10.3 ± 0.24 vs 7.4 ± 0.29) monocytes were significantly higher when compared with those of controls (all p 0.0001). Proportions of non-classical and intermediate monocytes correlated positively with serum levels of plasma cells, M-protein, calcium, creatinine and lactate dehydrogenase, and correlated negatively with the serum albumin level. Proportions of classical monocytes correlated positively with albumin level and negatively correlated with serum levels of M-protein, plasma cells, calcium, creatinine, and lactate dehydrogenase. Conclusion: Circulating monocyte subpopulations are skewed towards non-classical and intermediate monocytes in MM patients, and the intensity of this skewness increases with disease severity.
topic multiple myeloma
classical monocytes
intermediate monocytes
non-classical monocytes
flow cytometry
url https://ajlmonline.org/index.php/ajlm/article/view/1296
work_keys_str_mv AT asmaamzahran higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker
AT hanaanafadyhego higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker
AT sawsanmmoeen higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker
AT hananaeltyb higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker
AT mohammedmwahman higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker
AT asmaanafady higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker
_version_ 1717817598985371648